Malignant Progression in IPMN: A Cohort Analysis of Patients Initially Selected for Resection or Observation
about
International consensus on the management of intraductal papillary mucinous neoplasm of the pancreasPancreatic adenocarcinoma pathology: changing "landscape"Early detection and prevention of pancreatic cancer: is it really possible today?Intraductal Papillary Mucinous Neoplasm of PancreasPathological features and diagnosis of intraductal papillary mucinous neoplasm of the pancreas.Imaging patterns of intraductal papillary mucinous neoplasms of the pancreas: an illustrated discussion of the International Consensus Guidelines for the Management of IPMN.Current recommendations for surveillance and surgery of intraductal papillary mucinous neoplasms may overlook some patients with cancerPancreatic intraductal papillary mucinous neoplasm in a patient with Lynch syndrome.Targeted screening of individuals at high risk for pancreatic cancer: results of a simulation modelTumor-associated Neutrophils and Malignant Progression in Intraductal Papillary Mucinous Neoplasms: An Opportunity for Identification of High-risk DiseaseIntraductal Papillary Mucinous Neoplasms and the Risk of Diabetes Mellitus in Patients Undergoing Resection Versus Observation.Value of apparent diffusion coefficient for predicting malignancy of intraductal papillary mucinous neoplasms of the pancreas.Recurrence and Survival After Resection of Small Intraductal Papillary Mucinous Neoplasm-associated Carcinomas (≤20-mm Invasive Component): A Multi-institutional AnalysisCirculating tumour cells as a biomarker for diagnosis and staging in pancreatic cancer.Dysplasia at the surgical margin is associated with recurrence after resection of non-invasive intraductal papillary mucinous neoplasms.Is it necessary to follow patients after resection of a benign pancreatic intraductal papillary mucinous neoplasm?A pilot study of radiologic measures of abdominal adiposity: weighty contributors to early pancreatic carcinogenesis worth evaluating?Predicting dysplasia and invasive carcinoma in intraductal papillary mucinous neoplasms of the pancreas: development of a preoperative nomogram.Role of endoscopic ultrasonography in pancreatic cystic neoplasms: where do we stand and where will we go?Multi-Institutional Validation Study of Pancreatic Cyst Fluid Protein Analysis for Prediction of High-Risk Intraductal Papillary Mucinous Neoplasms of the Pancreas.Intraductal papillary mucinous neoplasm of the pancreas - epidemiology, risk factors, diagnosis, and management.Surveillance for neoplasia in the pancreasDevelopment and Validation of a Multi-Institutional Preoperative Nomogram for Predicting Grade of Dysplasia in Intraductal Papillary Mucinous Neoplasms (IPMNs) of the Pancreas: A Report from The Pancreatic Surgery Consortium.Survival Analysis and Risk for Progression of Intraductal Papillary Mucinous Neoplasia of the Pancreas (IPMN) Under Surveillance: A Single-Institution ExperienceImplications of imaging criteria for the management and treatment of intraductal papillary mucinous neoplasms - benign versus malignant findings.Natural History of Patients Followed Radiographically with Mucinous Cysts of the Pancreas.European evidence-based guidelines on pancreatic cystic neoplasms.
P2860
Q26772204-6E3562C6-44A6-4EE9-BA7B-0488EC17737AQ26799446-B7D4D952-59BF-4683-A508-AAD1D0D614B6Q26865704-CF8ED0E3-8439-40B1-986C-9D806B36029BQ27028114-68064806-983C-4F19-8513-79D0E56EFC66Q34179171-813FEB20-7CA2-4F8F-837E-D2363231B03CQ34438494-849E22DD-F412-4D84-8989-55EEFC801580Q35009641-FA7E2813-3D60-4033-89C2-74ACDF485B39Q35152407-65355955-0B93-4493-B81B-1CAE7760F03EQ35214109-9AA5EA15-F6C8-4E30-AC23-A0029C3DB2F9Q36275909-27890EB8-1DE1-425E-815B-B89A3AD080B4Q36734256-2A4A6885-5E98-4BAC-A0F0-0EA72AF66AD4Q37114824-70679A93-7B68-4C3D-B834-348769F5A908Q37117829-2F88E3AC-2081-4194-A4E9-D86126E59F58Q37174021-17F94ECD-730F-4C28-9379-AF10516ACE1DQ37216668-D4A81FD3-4C97-48B2-A417-01C06C0F5596Q37657085-6B1753C4-72FF-480D-BECA-9F0A289D0F73Q37720426-84734643-673B-48C2-8070-FFB8C67FEC11Q38138887-6F742654-2A89-4176-AA71-E756D650FBE4Q38161946-ADA21FA1-6A60-4794-B7D7-624949AF4D4DQ38682495-3C6CB487-CCDA-4C2D-8C55-DDF74ACD6A23Q38690531-FB896644-6196-4A5A-B717-AAA2FCFE7492Q38784725-04A69BFD-C388-4DEE-B65C-F468904CC272Q39025112-F3A4DB36-15E8-45C6-9693-BACB73E39F59Q39206243-5AA984A9-848A-4E1E-A264-E565BDB74AF7Q52871912-2C7561D1-F0DA-4766-B2A4-CF50D6F9EC99Q53286092-F90E7988-3A56-48BB-9AA4-DD1AE1F612DCQ54943890-369DD121-E6D9-4025-A9FB-895D1217C1C5
P2860
Malignant Progression in IPMN: A Cohort Analysis of Patients Initially Selected for Resection or Observation
description
article
@en
im Oktober 2012 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в жовтні 2012
@uk
name
Malignant Progression in IPMN: ...... d for Resection or Observation
@en
Malignant Progression in IPMN: ...... d for Resection or Observation
@nl
type
label
Malignant Progression in IPMN: ...... d for Resection or Observation
@en
Malignant Progression in IPMN: ...... d for Resection or Observation
@nl
prefLabel
Malignant Progression in IPMN: ...... d for Resection or Observation
@en
Malignant Progression in IPMN: ...... d for Resection or Observation
@nl
P2093
P2860
P50
P1476
Malignant progression in IPMN: ...... d for resection or observation
@en
P2093
C Correa-Gallego
D Klimstra
J Lafemina
M I D'Angelica
Peter J Allen
R P Dematteo
W R Jarnagin
P2860
P2888
P304
P356
10.1245/S10434-012-2702-Y
P577
2012-10-31T00:00:00Z
P6179
1012937048